About FutureChem
FutureChem is a company based in Seongdong (South Korea) founded in 1999 by Dae Yoon Chi.. The company has 87 employees as of December 31, 2024. FutureChem operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Denali Therapeutics, C4 Therapeutics and Erasca, among others.
- Headquarter Seongdong, South Korea
- Employees 87 as on 31 Dec, 2024
- Founders Dae Yoon Chi
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Futurechem Co., Ltd.
-
Annual Revenue
$11.72 M (USD)23.81as on Dec 31, 2024
-
Net Profit
$-6.39 M (USD)-40.37as on Dec 31, 2024
-
EBITDA
$-2.26 M (USD)-20.29as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
87
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of FutureChem
FutureChem is a publicly listed company on the KRX with ticker symbol 220100 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of FutureChem
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by FutureChem
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - FutureChem
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Futurechem Comparisons
Competitors of FutureChem
FutureChem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Denali Therapeutics, C4 Therapeutics and Erasca, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Futurechem
Frequently Asked Questions about FutureChem
When was FutureChem founded?
FutureChem was founded in 1999.
Where is FutureChem located?
FutureChem is headquartered in Seongdong, South Korea.
Who is the current CEO of FutureChem?
Dae Yoon Chi is the current CEO of FutureChem. They have also founded this company.
How many employees does FutureChem have?
As of Dec 31, 2024, the latest employee count at FutureChem is 87.
What is the annual revenue of FutureChem?
Annual revenue of FutureChem is $11.72M as on Dec 31, 2024.
What does FutureChem do?
FutureChem was founded in 1999 in Seongdong, South Korea, operating in the pharmaceutical sector focused on radioactive products. These are developed for diagnosing and treating cancer and neurological disorders. Specific offerings include 18F-FC303 for prostate cancer diagnosis and 177Lu-FC705 for its therapy. Additional items cover 18F-FMT for brain tumors, 18F-FC505 for atherosclerotic plaque, and 18F-FC211 for Alzheimers disease. Diagnostic solutions are provided for dementia, Parkinsons, and related conditions.
Who are the top competitors of FutureChem?
FutureChem's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Is FutureChem publicly traded?
Yes, FutureChem is publicly traded on KRX under the ticker symbol 220100.
What is FutureChem's ticker symbol?
The ticker symbol of FutureChem is 220100 on KRX.